Nipah Virus Infection Testing Market is expected to grow with a 5.2% CAGR from 2023 to 2033

During the forecast period 2023 to 2033, the Nipah virus (NiV) infection testing market is expected to grow at a value of 5.2% CAGR, according to Future Market Insights. By the year 2033, the global market for Nipah virus (NiV) infection testing is expected to rise up to a market valuation of US$ 3.277.49 million. The growth of the market can be attributed to the increasing prevalence of NiV infections across the globe. NiV is a zoonotic virus that can cause severe encephalitis and even death in humans.

Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16756

The NiV infection testing market has become an important part of public health monitoring and disease surveillance for governments, healthcare providers, and the medical community. The NiV infection testing market has seen several advancements over the years. The latest developments include improved nucleic acid-based tests that offer higher accuracy and faster results. This has helped reduce the risk of false positives and enabled healthcare providers to identify infected individuals more quickly.

In addition, the development of point-of-care testing devices for NiV infections has enabled healthcare providers to diagnose patients in remote areas without access to laboratory facilities. This has helped in the early detection and treatment of infected individuals in areas with limited healthcare resources. Furthermore, Asia Pacific along with Middle East and Africa are the largest contributors to the Nipah virus (NiV) infection testing market.

Key Takeaways from the Market Study

• The Nipah virus (NiV) infection testing market is expected to grow at a value of 5.2% CAGR in the forecast period 2023 to 2033
• By end user, hospitals are expected to possess 40% market share for Nipah virus (NiV) infection testing market in 2023.
• Asia Pacific is expected to possess 45% market share for Nipah virus (NiV) infection testing market in 2023.
• Middle East and Africa is expected to possess 39% market share for Nipah virus (NiV) infection testing market in 2023.

“The NiV infection testing market provides several benefits to the medical community and the general public. It enables healthcare providers to identify and treat infected individuals quickly and accurately. This helps reduce the spread of the virus and possible complications of the infection.” states an FMI analyst

Avail Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-16756

Competitive Landscape

Key players in the Nipah virus (NiV) infection testing market are Aurobindo, Minapharm, Roche, Lupin Ltd, Siegfried, Vivacure, Starlake Bioscience, Xaretto, Liferiver, MyBioSource, Krishgen Biosystems

• Aurobindo has developed a rapid diagnostic test for NiV, allowing clinicians to quickly detect the presence of the virus. Additionally, Aurobindo has used its expertise in the field of immunoassay and ELISA development to create an antibody test for NiV.
• In July 2020, Roche launched the cobas® NiV/HEV Assay. This test is a qualitative in-vitro diagnostic assay that detects NiV and HEV nucleic acid from human specimens and provides results in just under two hours.

Key Segments Profiled in the Nipah Virus (NiV) Infection Testing Industry Survey

Test Type:

• RT PCR based kits
• ELISA Kits

End User:

• Hospitals
• Research Labs
• Diagnostic Centres

Customization Available@ https://www.futuremarketinsights.com/customization-available/rep-gb-16756

About the Healthcare at Future Market Insights

The healthcare domain team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 Billion+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs